TIMH
BIIB icon

Tilt Investment Management Holdings’s Biogen BIIB Stock Holding History

Tilt Investment Management Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-751
Closed -$214K – 133
2023
Q2 		$214K Hold
751
– – 0.14% 143
2023
Q1 		$203K Buy
+751
New +$208K 0.15% 147

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tilt Investment Management Holdings's BIIB Position: Q3 2023 in Review

Tilt Investment Management Holdings sold out of Biogen (BIIB) in Q3 2023, closing a stake of 751 shares — an estimated $214K sold.

Tilt Investment Management Holdings first reported a position in BIIB in Q1 2023 and held it in 2 quarters. The position peaked at $214K in Q2 2023. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Tilt Investment Management Holdings reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Tilt Investment Management Holdings sold 751 Biogen shares in Q3 2023, an estimated $214K.
  • Tilt Investment Management Holdings first reported a position in Biogen in Q1 2023 and held it in 2 quarters.
  • Tilt Investment Management Holdings's Biogen position peaked at $214K in Q2 2023.
  • 966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.